MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Magnetic resonance imaging(MRI)"

  • 2025 International Congress

    CJD presenting as unilateral upper limb dystonia- rare presentation of an uncommon disease.

    N. Sawal, M. Matta, A. Kaur, S. Anand (Chandigarh, India)

    Objective: This case illustrates the importance of neuroimaging in any patient who presents with focal dystonia and it may be an early manifestation of a…
  • 2025 International Congress

    Evaluation of Perfusion, Iron Deposition, and Neuromelanin MRI Biomarkers Following Mesenchymal Stem Cell Treatment in a Phase 2 Parkinson’s Disease Trial

    J. Martinez-Lemus, E. Tharp, T. Ellmore, T. Thomas, C. Green, J. Suescun, C. Onuigbo, T. Le, E. Rodarte-Rascon, R. Ritter Iii, M. Schiess (Houston, USA)

    Objective: Evaluate the effects of allogeneic bone marrow-derived mesenchymal stem cell (allo-hMSC) infusions on neuroimaging biomarkers in patients with Parkinson’s disease (PD) using different MRI…
  • 2025 International Congress

    Clinical and Neuroimaging Findings in ANO10-Related Cerebellar Ataxia: Evidence of Widespread Brain Atrophy

    A. Milovanović, O. Tamaš, N. Mazalica, S. Pisano, S. Basaia, F. Agosta, M. Filippi, V. Kostić, N. Dragašević-Mišković (Milan, Italy)

    Objective: The aim of this study was to evaluate clinical manifestations and magnetic resonance imaging (MRI) changes in patients with ANO10 gene mutations. Background: Neurodegenerative…
  • 2025 International Congress

    Increased Basal Ganglia And Default-Mode Network Connectivity And Altered Deep Gray Matter Volume In Functional Movement Disorders

    E. Sarasso, A. Gardoni, M. Gandolfi, L. Zenere, S. Basaia, E. Canu, E. Sibilla, A. Sandri, IA. Di Vico, M. Fiorio, G. Pedrotti, A. Paolicelli, P. Barone, MT. Pellecchia, R. Erro, S. Cuoco, I. Carotenuto, C. Vinciguerra, A. Botto, M. Amboni, M. Russo, G. Mansueto, FB. Pizzini, M. Barillari, MF. Lauriola, MC. Tozzi, F. Rusciano, C. Geroin, M. Fasoli, A. Marotta, E. Pizzolla, F. Salaorni, I. Lozzi, F. Bombieri, GM. Squintani, S. Mariotto, S. Tamburin, F. Paio, G. de Biasi, G. Piscosquito, M. Tinazzi, M. Filippi, F. Agosta (Milan, Italy)

    Objective: This study aims to investigate alterations in brain functional connectivity (FC) and deep gray matter volume in patients with Functional Movement Disorders (FMD) compared…
  • 2025 International Congress

    Decreased DTI-ALPS Indices and their Association with Clinical Features in Parkinson’s Disease

    J. Pardo, I. Roura, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, J. Oltra, A. Campabadal, N. Bargalló, MA. Jurado, M. Garolera, MJ. Martí, Y. Compta, C. Junqué, B. Segura (Barcelona, Spain)

    Objective: To investigate possible glymphatic dysfunction using diffusion tensor image along the perivascular space (DTI-ALPS) in patients with Parkinson’s disease and their relationship with clinical…
  • 2025 International Congress

    Turning Points in Disease Progression: Detecting MRI Biomarker Transitions in SCA3 Using Longitudinal Data

    M. Ferreira, P. Wegner, T. Klockgether, J. Faber (Bonn, Germany)

    Objective: This study aims to identify data-driven turning points in MRI biomarkers of SCA3 to characterize region-specific disease transitions and inform early intervention strategies. Background: SCA3…
  • 2025 International Congress

    Impact 360 Study for Parkinson’s Disease – a controlled phase II feasibility and safety study of a combined exercise, diet and mindfulness intervention

    J. Kelly, M. Powell, R. Cloke, J. Yu, S. Stelling, T. Watson, A. Hashimoto, A. Kuan, M. Sacheli, Y. Wang, D. Darabi, S. Appel-Cresswell (Vancouver, Canada)

    Objective: The aim of this phase II controlled trial is to evaluate the safety, feasibility, and to explore the effects of a multimodal intervention in…
  • 2025 International Congress

    Longitudinal MRI Study of Hippocampal Subfields Morphometry in Early Parkinson’s Disease

    T. Wu, S. Ng, T. Teo, X. Choi, D. Heng, S. Neo, Z. Xu, K. Tay, W. Au, E. Tan, L. Chan, L. Tan, T. Welton (Singapore, Singapore)

    Objective: This prospective cohort study longitudinally investigated hippocampal subfield shape deformation and atrophy in early-stage Parkinson’s Disease (PD), using spherical harmonic-based shape analysis. Background: Hippocampal…
  • 2025 International Congress

    Machine Learning Analysis of DTI-Derived Free Water Reveals Distinct Parkinson’s Disease Subtypes: A Two-Year Longitudinal Study

    A. Vijayakumari, H. Fernandez, B. Walter (Cleveland, USA)

    Objective: To identify distinct subtypes of Parkinson’s disease (PD) based on diffusion tensor imaging (DTI)-derived free water (FW) patterns in basal ganglia (BG) structures using…
  • 2025 International Congress

    Brain Structural Impairment in Spinocerebellar Ataxia Type 6: Not Restricted to the Cerebellum

    B. Massuyama, T. Rezende, M. Junior, O. Barsottini, J. Pedroso (Campinas, Brazil)

    Objective: To characterize the structural brain signature in SCA6 patients. Background: Spinocerebellar ataxias (SCA) refer to a group of autosomal dominant ataxic disorders that result…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 78
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley